REBECCA M. ALLEN, MD MPH

Director of Neuropsychiatry and Research

Overview

Dr. Allen has authored several papers and participated in research on sleep and memory consolidation, quality of life in multiple sclerosis, comparing TMS protocols and other projects. She authored a chapter on Sleep and Sleep Disorders for the Harvard textbook Neuropsychiatry and Behavioral Neurology: Principles and Practice (2020).  She is trained in the neurobiological bases and treatment of cognitive and behavioral manifestations of neurodegenerative diseases (dementia), multiple sclerosis, epilepsy, stroke, brain tumors, developmental disorders, traumatic brain injury and other disorders. Dr. Allen’s current focus is on brain stimulation and interventional treatments for neuropsychiatric conditions, including transcranial magnetic stimulation, electroconvulsive therapy, vagus nerve stimulation, ketamine, and esketamine. As our Director of Research she also oversees clinical trials of novel therapies. She has held local and national leadership positions, including serving as a Member of the Board of the Clinical TMS Society, as chair of the Insurance Committee of the Clinical TMS Society, as the President Elect of the Clinical TMS Society for 2022-23, and as the President of the Washington State Psychiatric Association for 2020-21

Patient Care Philosophy

“One of my most important goals in a first meeting with a patient is to learn the patient’s perspective on what is causing them suffering, and what needs to improve. I enjoy teaching patients about treatments and answering questions. But my favorite part of the job is seeing people get better.”

Education and Training

Fellowships: Neuropsychiatry at Brigham and Women’s Hospital
Residency: Harvard Longwood Psychiatry Residency Training Program
Medical School: Oregon Health and Science University
College: Stanford University